참고문헌 (17)

1. J. Med. Chem. M. J. Ashton 37 1696 1994 10.1021/jm00037a021 Ashton, M. J., Cook, D. C., Fenton, G., Karlsson, J. A., Palfreyman, M. N., Raeburn, D., Ratcliffe, A. J., Souness, J. E., Thurairatnam, S. and Vicker, N., Selective type IV phosphodiesterase inhibitors as antiasthmatic agents. The syntheses and biological activities of 3-(cyclopentyloxy)-4-methoxybenzamides and analogues.J. Med. Chem., 37, 1696-1703 (1994). 

   상세보기

2. J. Pharmacol. Exp. Ther. M. S. Barnette 273 1396 1995 Barnette, M. S., Grous, M., Cieslinski, L. B., Burman, M., Christensen, S. B. and Torphy, T. J., Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site.J. Pharmacol. Exp. Ther., 273, 1396-1402 (1995). 

   상세보기

3. Mol. Pharmacol. J. A. Beavo 46 399 1994 Beavo, J. A., Conti, M. and Heaslip, R. J., Multiple cyclic nucleotide phosphodiesterases.Mol. Pharmacol., 46, 399-405 (1994). 

   상세보기

4. Trends Pharmacol. Sci. J. A. Beavo 11 150 1990 10.1016/0165-6147(90)90066-H Beavo, J. A. and Reifsnyder, D. H., Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors.Trends Pharmacol. Sci., 11, 150-155 (1990). 

   상세보기

5. J. Med. Chem. S. B. Christensen 41 821 1998 10.1021/jm970090r Christensen, S. B., Guider, A., Forster, C. J., Gleason, J. G., Bender, P. E., Karpinski, J. M., DeWolf, W. E. Jr., Barnette, M. S., Underwood, D. C., Griswold, D. E., Cieslinski, L. B., Burman, M., Bochnowicz, S., Osborn, R. R., Manning, C. D., Grous, M., Hillegas, L. M., Bartus, J. O., Ryan, M. D., Eggleston, D. S., Haltiwanger, R. C. and Torphy, T. J., 1,4-Cyclohexanecarboxylates: potent and selective inhibitors of phosphodiesterase 4 for the treatment of asthma.J. Med. Chem., 41, 821-835 (1998). 

   상세보기

6. J. Allergy Clin. Immunol. V. L. Cohan 95 350 1995 Cohan, V. L., Showell, H. J., Pettipher, E. R., Fisher, D. A., Pazzoles, C. J., Watson, J. W., Turner, C. R. and Cheng, J. B.,In vitro pharmacology of the novel type IV phosphodiesterase (PDEIV) inhibitor, CP-80,633.J. Allergy Clin. Immunol., 95, 350 (1995) [Abstract]. 

7. Br. J. Pharmacol. J. Cortijo 108 562 1993 10.1111/j.1476-5381.1993.tb12841.x Cortijo, J., Bou, J., Beleta, J., Cardelus, I., Llenas, J., Motciool, E. and Gristwood, R. W., Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus.Br. J. Pharmacol., 108, 562-56 (1993). 

   상세보기

8. Mol. Cell. Endocrinol. C. Erneux 43 123 1985 10.1016/0303-7207(85)90075-9 Erneux, C., Van Sande, J., Milot, F., Cochaux, P., Decosster, C. and Dumont, J. E., A mechanism in the control of intracellular cAMP level: the activation of a calmodulin-sensitive phosphodiesterase by a rise of intracellular free calcium.Mol. Cell. Endocrinol., 43, 123-134 (1985). 

   상세보기

9. Br. J. Pharmacol. M. Holbrook 118 1192 1996 10.1111/j.1476-5381.1996.tb15523.x Holbrook, M., Gozzard, N., James, T., Higgs, G. and Hughes, B., Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guineapig by CDP840, a novel phosphodiesterase type 4 inhibitor.Br. J. Pharmacol., 118, 1192-1200 (1996). 

   상세보기

10. Immunol. Today G. M. Kammer 9 222 1988 10.1016/0167-5699(88)91220-0 Kammer, G. M., The adenylate cyclase-cAMP-protein kinase pathway and regulation of immune response.Immunol. Today 9, 222-229 (1988). 

    상세보기

11. J. Org. Chem. J. E. Lynch 62 9223 1997 10.1021/jo971476c Lynch, J. E., Choi, W.-B., Churchill, H. R. O., Volante, R. P., Reamer, R. A. and Ball, R. G., Asymmetric synthesis of CD840 by Jacobsen Epoxidation. An usual Syn selective reduction of an epoxide.J. Org. Chem., 62, 9223-9228 (1997). 

    상세보기

12. J. Med. Chem. M. C. Marivet 32 1450 1989 10.1021/jm00127a009 Marivet, M. C., Bourguignon, J.-J., Lugnier, C., Mann, A., Stoclet, J.-C. and Wermuth, C., Inhibition of cyclic adenosine-3′,5′-monophosphate phosphodiesterase from vascular smooth muscle by rolipram analogues.J. Med. Chem., 32, 1450-1457 (1989). 

    상세보기

13. Trends Pharmacol. Sci. C. Nicholson 12 19 1991 10.1016/0165-6147(91)90484-A Nicholson, C., Challis, R. and Shakio, M., Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.Trends Pharmacol. Sci., 12, 19-27 (1991). 

    상세보기

14. Psychopharmacology R. Schmiechen 102 17 1990 10.1007/BF02245738 Schmiechen, R., Schneider, H. H. and Watchtel, H., Close correlation between behavioral response and bindingin vivo for inhibitors of the rolipram-sensitive phosphodiesterase.Psychopharmacology, 102, 17-20 (1990). 

    상세보기

15. Thorax T. J. Torphy 46 512 1991 10.1136/thx.46.7.512 Torphy, T. J. and Undem, B. J., Phosphodiesterase inhibitors: New opportunities for the treatment of asthma.Thorax 46, 512-523 (1991). 

    상세보기

16. J. Comp. Chem. A. Smellie 16 171 1995 10.1002/jcc.540160205 Smellie, A., Teig, S. L. and Towbin, P., “Poling: Promoting Conformational Coverage”.J. Comp. Chem., 16, 171-187 (1995). 

    상세보기

17. J. Med. Chem. R. E. Weishaar 28 537 1985 10.1021/jm50001a001 Weishaar, R. E., Cain, M. H. and Bristol, J. A., A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.J. Med. Chem., 28, 537-545 (1985). 

    상세보기

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.